QuiaPEG Pharmaceuticals Holding AB Working Capital to Net Assets Ratio
QuiaPEG Pharmaceuticals Holding AB working capital to net assets ratio. QuiaPEG Pharmaceuticals Holding AB (QUIA) has a Working Capital to Net Assets ratio of -124.1% as of June 2025. Working capital of Skr-8.03 Million (current assets of Skr779.00K minus current liabilities of Skr8.81 Million) is measured against net assets of Skr6.47 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check QuiaPEG Pharmaceuticals Holding AB (QUIA) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of QuiaPEG Pharmaceuticals Holding AB (2008–2024)
Working capital to net assets ratio of QuiaPEG Pharmaceuticals Holding AB from 2008 to 2024. This chart shows how QuiaPEG Pharmaceuticals Holding AB's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2008 to 2024. As of June 2025, the ratio stands at -124.1%, reflecting working capital of Skr-8.03 Million against net assets of Skr6.47 Million SEK. See QuiaPEG Pharmaceuticals Holding AB defensive interval ratio to measure how many days the company can operate on defensive assets alone.
QuiaPEG Pharmaceuticals Holding AB Working Capital to Net Assets Ratio by Year (2008–2024)
QuiaPEG Pharmaceuticals Holding AB working capital to net assets ratio by year from 2008 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for QuiaPEG Pharmaceuticals Holding AB from 2008 to 2024, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see QUIA current and non-current assets.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -32.7% | Skr-5.35 Million | Skr16.35 Million | Skr1.05 Million | Skr6.39 Million | ▲ +130.8 pp |
| 2023 | -163.6% | Skr-24.94 Million | Skr15.25 Million | Skr1.76 Million | Skr26.71 Million | ▼ -78.1 pp |
| 2022 | -85.4% | Skr-2.06 Million | Skr2.41 Million | Skr3.76 Million | Skr5.82 Million | ▲ +1864.6 pp |
| 2021 | -1950.0% | Skr-429.00K | Skr22.00K | Skr6.29 Million | Skr6.72 Million | ▲ +11940.1 pp |
| 2020 | -13890.1% | Skr-9.86 Million | Skr71.00K | Skr9.46 Million | Skr19.32 Million | ▼ -13947.0 pp |
| 2019 | 56.9% | Skr-4.88 Million | Skr-8.57 Million | Skr5.37 Million | Skr10.24 Million | ▲ +562.4 pp |
| 2018 | -505.5% | Skr-2.75 Million | Skr545.00K | Skr3.55 Million | Skr6.30 Million | ▼ -540.9 pp |
| 2017 | 35.4% | Skr2.14 Million | Skr6.04 Million | Skr6.32 Million | Skr4.19 Million | ▼ -51.1 pp |
| 2016 | 86.5% | Skr15.94 Million | Skr18.44 Million | Skr19.59 Million | Skr3.65 Million | ▲ +13.7 pp |
| 2015 | 72.8% | Skr5.04 Million | Skr6.92 Million | Skr6.71 Million | Skr1.67 Million | ▲ +12.3 pp |
| 2014 | 60.5% | Skr3.90 Million | Skr6.44 Million | Skr7.03 Million | Skr3.14 Million | ▲ +1.1 pp |
| 2013 | 59.4% | Skr4.30 Million | Skr7.24 Million | Skr7.90 Million | Skr3.59 Million | ▼ -5.4 pp |
| 2012 | 64.8% | Skr6.30 Million | Skr9.73 Million | Skr13.19 Million | Skr6.89 Million | ▲ +7.6 pp |
| 2011 | 57.2% | Skr7.99 Million | Skr13.98 Million | Skr10.39 Million | Skr2.40 Million | ▲ +19.6 pp |
| 2010 | 37.5% | Skr6.44 Million | Skr17.17 Million | Skr8.06 Million | Skr1.62 Million | ▲ +6.8 pp |
| 2009 | 30.7% | Skr5.47 Million | Skr17.82 Million | Skr6.87 Million | Skr1.40 Million | ▲ +9.7 pp |
| 2008 | 20.9% | Skr3.76 Million | Skr17.98 Million | Skr5.52 Million | Skr1.76 Million | — |